30-second blood test promises to improve care to at-risk populations

An innovative new development in blood testing may help some of the most vulnerable populations. The assay is able to determine an individual's blood type in just 30 seconds, a significant shortened timeframe compared to many conventional tests that can take 20 minutes.

The dye-assisted paper-based test, described in Science Translational Medicine, may lead to improved emergency response in remote settings or areas of conflict. The test could allow for faster blood transfusions or organ transplants.

"Hong Zhang, the study author and a researcher at Third Military Medical University in Chongqing, China, and his colleagues used the test to analyze 3,550 blood samples, which were obtained either using a blood draw or a finger prick," according to STAT. It was accurate more than 99.9 percent of the time — the only accuracy issues cropped up when testing highly uncommon blood types."

Read more here:

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.